Mahoney R T, Maynard J E
International Vaccine Institute, and International Task Force on Hepatitis B Immunization, Seoul National University Campus, South Korea.
Vaccine. 1999 Feb 26;17(7-8):646-52. doi: 10.1016/s0264-410x(98)00246-1.
The development and introduction of new vaccines is a costly and time consuming process. Unfortunately, those most in need--individuals in developing countries--are the last to receive these powerful disease preventing products. From the time a vaccine is first licensed in a developed country to the time most of the poor in developing countries have access to the vaccine can be 20-30 years. This delay is unacceptable. There is a great need to reduce this time span. This paper examines five ways of reducing the time span. Each of the five is essential and achieving success on all five will require a heightened level of international effort and coordination.
新疫苗的研发和推广是一个成本高昂且耗时的过程。不幸的是，最需要这些疫苗的人群——发展中国家的民众——却是最后才能够获得这些强大的疾病预防产品。从一种疫苗在发达国家首次获得许可，到大多数发展中国家的贫困人口能够使用该疫苗，这中间可能会间隔20至30年。这种延迟是不可接受的。迫切需要缩短这一时间跨度。本文探讨了缩短这一时间跨度的五种方法。这五种方法中的每一种都是必不可少的，要在所有五个方面都取得成功，将需要更高水平的国际努力与协调。
